← back to search

Sangeeta R. Kashyap

Cornell University · US
Area of research
Surgery · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Bariatric Surgery and Outcomes, Diet and metabolism studies, Diabetes Treatment and Management, and Diabetes, Cardiovascular Risks, and Lipoproteins.
h-index
48
citations
18,984
works
237
NIH funding
primary concept
Medicine
email

Recent publications

Approach to the Patient: Clinical Outcomes and Interim Strategies Following Discontinuation of Incretin Agonists.
2026cited by 0position: contributordoi
Effect of Social Vulnerability on Efficacy of Bariatric Surgery Versus Medical and Lifestyle Intervention for Type 2 Diabetes: Analysis of the ARMMS-T2D Consortium of Randomized Trials.
2026cited by 0position: contributordoi
Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesity: The ARMMS-T2D Study
Diabetes Care 2025cited by 12position: middledoi
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches
The Lancet Diabetes & Endocrinology 2025cited by 9position: lastdoi
Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes
JAMA 2024cited by 232position: middledoi
Potential Mechanisms of Precision Nutrition-Based Interventions for Managing Obesity
Advances in Nutrition 2024cited by 30position: middledoi
Approach to the Patient: Normocalcemic Primary Hyperparathyroidism
The Journal of Clinical Endocrinology & Metabolism 2024cited by 15position: middledoi
Long-term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction-associated fatty liver disease in adults with obesity and type 2 diabetes.
2024cited by 2position: contributordoi
Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
Alzheimer s Research & Therapy 2023cited by 67position: middledoi
Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
2023cited by 51position: contributordoi
Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study
Journal of Diabetes and its Complications 2023cited by 11position: contributordoi
Glycemic and metabolic sub-classification of prediabetes and risk factors for cardiovascular disease in the D2d cohort.
2023cited by 4position: contributordoi
Prevalence and clinical determinants of non-alcoholic fatty liver disease by liver scores in adults with type 1 diabetes.
2023cited by 3position: contributordoi
Insulin Independence With SGLT2 Inhibitor Use in Type 2 Diabetes.
2023cited by 0position: contributordoi
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
Endocrine Practice 2022cited by 931position: middledoi
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).
2022cited by 655position: contributordoi
Diabetes Remission in the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D).
2022cited by 76position: contributordoi
Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes.
2022cited by 37position: contributordoi
Variations in Sleep Characteristics and Glucose Regulation in Young Adults With Type 1 Diabetes.
2022cited by 26position: contributordoi
Impact of Metabolic Syndrome on Severity of COVID-19 Illness.
2022cited by 17position: contributordoi
Early Post-Renal Transplant Hyperglycemia.
2022cited by 13position: contributordoi
The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study.
2022cited by 11position: contributordoi
Obesity-associated sleep hypoventilation and increased adverse postoperative bariatric surgery outcomes in a large clinical retrospective cohort.
2022cited by 9position: contributordoi
Association between first-line monotherapy with metformin and the risk of atrial fibrillation (AMRAF) in patients with type 2 diabetes.
2022cited by 7position: contributordoi
Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D): Study rationale, design, and methods.
2022cited by 7position: contributordoi
Prevalence and Clinical Determinants of Obesity in Adults With Type 1 Diabetes Mellitus: A Single-Center Retrospective Observational Study.
2022cited by 6position: contributordoi
Perioperative management of diabetes in patients undergoing bariatric and metabolic surgery: a narrative review and the Cleveland Clinic practical recommendations.
2022cited by 5position: contributordoi
Bariatric Surgery: It's Not Just Incretins!
2022cited by 3position: contributordoi
Effects of Metabolic Medicine and Metabolic Surgery on Patient-Reported Outcomes Among Patients with Type 2 Diabetes.
2022cited by 2position: contributordoi
Metabolic labeling unveils alterations in the turnover of HDL-associated proteins during diabetes progression in mice.
2022cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

John P. Kirwan · Providence College11 papers (2012–2026)Philip R. Schauer · Providence College9 papers (2012–2025) · 7 papers (2022–2026)Donald C. Simonson · Harvard University5 papers (2022–2026)Mary‐Elizabeth Patti · Providence College5 papers (2022–2026)Karen Johnson · University of Tennessee Health Science Center5 papers (2018–2022)Deepak L. Bhatt · Technische Universität Dresden5 papers (2012–2017)Ali Aminian · Cleveland Clinic4 papers (2014–2025)Kathy Wolski · Cleveland Clinic4 papers (2012–2017)David Arterburn · Kaiser Permanente Washington Health Research Institute4 papers (2022–2025)Stacy A. Brethauer · The Ohio State University Wexner Medical Center4 papers (2012–2017)Sun H. Kim · Horizon Therapeutics (United States)4 papers (2021–2023)Steven E. Nissen · Esperion Therapeutics (United States)4 papers (2012–2017) · 4 papers (2012–2017)Thomas P. J. Solomon · University of Birmingham3 papers (2013–2017)Rowena J Dolor · Duke University3 papers (2021–2022)Anastassios G. Pittas · Tufts Medical Center3 papers (2018–2022)Ali Aminian · Cleveland Foundation3 papers (2022–2026)Erin S. LeBlanc · Maine Medical Center3 papers (2021–2022) · 3 papers (2022–2026)